Altria Group is set to perform an equity and inclusion assessment. This assessment stems from a shareholder proposal made last year, which suggested that Altria commission an audit of equity and inclusion rights and seek to address feedback received from recent shareholder engagement.
This assessment will review Altria's policies, practices, plans, and services aimed at addressing the harms associated with tobacco use, as well as the effectiveness of the company's efforts to reduce harm, including underage tobacco prevention programs, smoking cessation support, responsible marketing practices and regulatory involvement, and public policy engagement. The assessment will include an evaluation of these policies, practices, plans, and services targeted at communities of color and youth, as well as the company's progress in inclusion, diversity, and equity (ID&E).
Altria will lead an evaluation that will be supervised by an external consulting review committee. This committee is composed of independent third-party members who have relevant expertise in areas such as civil rights, identity and equity, law/enforcement, public policy, public health, and youth development. The external consulting review committee will provide recommendations and monitor the evaluation, including its scope, stakeholder engagement, and the presentation of investigation results in the final published report. This report will be guaranteed by third-party companies.
Altria plans to release a report discussing the evaluation results on its website within 12 months after the assessment begins.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
